2022
DOI: 10.1159/000522038
|View full text |Cite
|
Sign up to set email alerts
|

The Next Evolution of HemoDialysis eXpanded: From a Delphi Questionnaire-Based Approach to the Real Life of Italian Dialysis Units

Abstract: <b><i>Introduction:</i></b> Impact assessment of new technologies in chronic hemodialysis (HD) is challenging due to HD patient frailty, the complexity of HD clinical trials and practice variability among countries. Among the most recent HD innovations, medium cut-off (MCO) dialyzers present an optimized membrane geometry that provides enhanced clearances for middle and large molecular weight uremic toxins (UT). These toxins are poorly cleared by available HD techniques and largely cont… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 57 publications
(69 reference statements)
0
4
0
Order By: Relevance
“…Validity is related to the purpose of measurement. The same measurement tool has high validity in some measurements, but not in others [ 19 ]. For example, a ruler with high reliability has good validity in measuring height, but not in measuring blood pressure.…”
Section: Methodsmentioning
confidence: 99%
“…Validity is related to the purpose of measurement. The same measurement tool has high validity in some measurements, but not in others [ 19 ]. For example, a ruler with high reliability has good validity in measuring height, but not in measuring blood pressure.…”
Section: Methodsmentioning
confidence: 99%
“…Hemodiafiltration and medium cut-off (MCO) dialyzers applied to standard hemodialysis, defined as "expanded hemodialysis" (HDx), improved the elimination of middle-to large-sized molecular toxins [103,104], see Figure 1.…”
Section: Uremic Toxin Involvementmentioning
confidence: 99%
“…Whereas several studies have assessed the relationship between FLCs and mortality risk in chronic kidney disease (CKD) [ 31 , 32 , 33 ], FLCs received only marginal attention as uremic toxins in non-multiple myeloma HD patients. Lamy evaluated their reduction with different dialyzers, revealing a better removal of κFLCs, but not λFLCs, after hemodiafiltration (HDF) if compared to bicarbonate dialysis [ 34 ]; expanded HD (HDx), based on medium cut-off (MCO) dialyzers, recently demonstrated non-inferiority results about FLC removal, when compared with HDF data [ 35 , 36 ].…”
Section: Introductionmentioning
confidence: 99%